177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Indiana University
Weill Medical College of Cornell University
Mario Negri Institute for Pharmacological Research
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Merck Sharp & Dohme LLC
Fudan University
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Celgene
Albert Einstein College of Medicine
Sun Yat-sen University
Merck Sharp & Dohme LLC
Kyntra Bio
University of Utah
M.D. Anderson Cancer Center
National Cancer Center, Korea
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Stanford University
Hoffmann-La Roche
Memorial Sloan Kettering Cancer Center
University of Louisville
Tarix Pharmaceuticals
Mayo Clinic
Samsung Medical Center
German CLL Study Group
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Rigshospitalet, Denmark
TME Pharma AG
Amgen
Amgen
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Amgen
Amgen
Amgen
Amgen
Affymax
Jonsson Comprehensive Cancer Center
University of California, San Francisco
Kyowa Kirin Co., Ltd.
Northwestern University
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.